| Literature DB >> 6538658 |
M E Charness, F Morady, M M Scheinman.
Abstract
Fifty-four consecutive patients were treated with amiodarone for symptomatic ventricular tachycardia or ventricular fibrillation refractory to treatment with conventional antiarrhythmic drugs. A reversible neurologic syndrome of tremor, ataxia, and occasionally peripheral neuropathy without nystagmus, dizziness, encephalopathy, or long-tract signs developed in 54% of the patients and was the most common reason for altering or discontinuing drug therapy. Neurologic side effects improved or resolved within 2 days to 4 weeks of decreasing or discontinuing amiodarone. Frequent neurologic toxicity is a hitherto undescribed complication of amiodarone therapy. Wider recognition of this syndrome will avoid unnecessary and costly diagnostic evaluation.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6538658 DOI: 10.1212/wnl.34.5.669
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910